Page last updated: 2024-10-21

8-hydroxy-2-(di-n-propylamino)tetralin and Experimental Mammary Neoplasms

8-hydroxy-2-(di-n-propylamino)tetralin has been researched along with Experimental Mammary Neoplasms in 2 studies

8-Hydroxy-2-(di-n-propylamino)tetralin: A serotonin 1A-receptor agonist that is used experimentally to test the effects of serotonin.
8-OH-DPAT : A tetralin substituted at positions 1 and 7 by hydroxy and dipropylamino groups respectively

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19901 (50.00)18.7374
1990's0 (0.00)18.2507
2000's1 (50.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Mück-Seler, D1
Pivac, N1
Cory, RN1
Rouot, B1
Guillon, G1
Sladeczek, F1
Balestre, MN1
Bockaert, J1

Other Studies

2 other studies available for 8-hydroxy-2-(di-n-propylamino)tetralin and Experimental Mammary Neoplasms

ArticleYear
The effect of natural clinoptilolite on the serotonergic receptors in the brain of mice with mammary carcinoma.
    Life sciences, 2003, Sep-05, Volume: 73, Issue:16

    Topics: 8-Hydroxy-2-(di-n-propylamino)tetralin; Animals; Antineoplastic Agents; Brain; Diet; Female; Mammary

2003
The 5-hydroxytryptamine (5-HT2) receptor stimulates inositol phosphate formation in intact and broken WRK1 cells: determination of occupancy-response relationships for 5-HT agonists.
    The Journal of pharmacology and experimental therapeutics, 1987, Volume: 241, Issue:1

    Topics: 5-Methoxytryptamine; 8-Hydroxy-2-(di-n-propylamino)tetralin; Animals; Bufotenin; Cell Line; Dibenzyl

1987